Long-acting amylin analog (CagriSema partner compound) for dual amylin/GLP-1 metabolic research. Fatty acid conjugated for extended half-life.
Cagrilintide is a long-acting amylin analog designed for once-weekly dosing in research settings. It is a 37-amino acid peptide with multiple modifications including fatty acid conjugation that enables albumin binding and extends plasma half-life. Cagrilintide is the amylin-analog component of the investigational combination CagriSema, making it a key compound for studying dual amylin/GLP-1 receptor co-agonism in metabolic research.
SPPS synthesis with modification steps; HPLC >=99%; LC-MS confirmed; LAL endotoxin tested. Full CoA provided.
For Research Use Only. Not for human or veterinary use.
| Product Name | Cagrilintide |
| CAS Number | 2418601-04-2 |
| Purity | ≥99% (by HPLC) |
| Molecular Weight | 3,760.24 g/mol |
| Molecular Formula | C166H265N45O53 |
| Appearance | White to off-white lyophilized powder |
| Storage | Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C. |
| Available Sizes | 10mg · Custom |
Store at -20C desiccated. Stable >=24 months. Reconstituted: use within 7 days at 2-8C.
24 months from manufacture when stored properly.
Cold-chain shipping with ice packs. Express delivery to 35+ countries.
Get premium research-grade peptides with complete documentation and worldwide delivery.
Cagrilintide · CAS 2418601-04-2
Quote request sent! We'll respond within 24 hours.
